实用肿瘤学杂志 ›› 2025, Vol. 39 ›› Issue (6): 464-470.doi: 10.11904/j.issn.1002-3070.2025.06.002

• 治疗质量专题 • 上一篇    下一篇

结直肠癌住院手术患者治疗过程质量得分及其影响因素分析

姚慧鑫, 武金亚, 郭玲琪, 刘美娜   

  1. 哈尔滨医科大学公共卫生学院卫生统计学教研室(哈尔滨 150081)
  • 收稿日期:2025-02-11 修回日期:2025-11-13 出版日期:2025-12-28 发布日期:2026-01-13
  • 通讯作者: 刘美娜,E-mail:liumeina369@163.com
  • 作者简介:姚慧鑫,男,(1999—),硕士研究生,从事恶性肿瘤治疗质量评价的研究。
  • 基金资助:
    国家自然科学基金(编号:82173614)

Analysis of the quality scores and factors influencing the treatment process for colorectal cancer patients undergoing surgery

YAO Huixin, WU Jinya, GUO Lingqi, LIU Meina   

  1. Department of Biostatistics,Public Health College of Harbin Medical University,Harbin 150081,China
  • Received:2025-02-11 Revised:2025-11-13 Online:2025-12-28 Published:2026-01-13

摘要: 目的 评价结直肠癌住院手术患者治疗过程质量水平,并探讨其影响因素,为改进结直肠癌临床治疗质量提供参考。方法 收集2018年3月至2023年3月在哈尔滨医科大学附属肿瘤医院进行手术治疗的结直肠癌患者病历信息,选取9项治疗过程质量评价指标计算个体得分,并以得分中位数将患者划分为高、低治疗过程质量组。比较高、低治疗过程质量组在临床及基线特征上的差异,并分析治疗过程质量的影响因素。结果 纳入12 502例患者,治疗过程质量得分中位数为0.44。结直肠癌家族史、吸烟情况、身体质量指数(body mass index,BMI)、医保类型、粪便检查、内分泌治疗、化疗及饮酒等在高、低治疗过程质量组间差异均具有统计学意义(P<0.05)。多因素logistic回归分析结果显示,接受粪便检查、接受内分泌治疗、接受化疗和饮酒与较低治疗过程质量相关(P<0.05);结直肠癌家族史、BMI高、吸烟和具有其他医疗保险与较高治疗过程质量相关(P<0.05)。结论 在临床治疗中应加强过程指标的应用,重点关注无结直肠癌家族史、偏瘦及饮酒患者的管理;未接受粪便检查和未接受内分泌治疗与较高治疗过程质量的关联尚需进一步研究解释与验证。

关键词: 结直肠癌, 治疗过程质量, 影响因素

Abstract: Objective The aim of this study was to evaluate the quality level of treatment process for hospitalized surgical patients with colorectal cancer and explore its influencing factors,providing reference for improving the clinical treatment quality of colorectal cancer. Methods Medical record data were collected for patients with colorectal cancer who underwent surgical treatment at Harbin Medical University Cancer Hospital from March 2018 to March 2023.Nine process quality evaluation indicators were selected to calculate an individual scores,and patients were categorized into the high-and low-quality groups based on the median scores.The differences were compared in clinical and baseline characteristics between the high-and low-quality treatment process quality groups and to analyze the factors influencing treatment process quality. Results A total of 12,502 patients were included,with a median treatment process quality score of 0.44.There were statistically significant differences in family history of colorectal cancer,smoking status,body mass index(BMI),medical insurance type,fecal examination,endocrine therapy,chemotherapy,and alcohol consumption between the high-and low-treatment quality groups(P<0.05).Multivariable logistic regression analysis showed that undergoing fecal testing,receiving endocrine therapy,receiving chemotherapy,and alcohol consumption were associated with a lower quality of the treatment process(P<0.05).A family history of colorectal cancer,higher BMI,smoking,and having other types of medical insurance were associated with a higher quality of the treatment process(P<0.05). Conclusion In clinical treatment,the application of process indicators should be strengthened,with a focus on the management of patients without a family history of colorectal cancer,underweight,and alcohol consumption.The associations between not receiving fecal examination and not receiving endocrine therapy and higher treatment process quality still needs further investigation,explanation,and verification.

Key words: colorectal cancer, quality of treatment process quality, influencing factors

中图分类号: